Ramdan Hours:
Sun - Thu
9.30 AM - 2.30 PM
Iftar in --:--:--
🌙 Maghrib: --:--
Image from Google Jackets

Excipient toxicity and safety / edited by Myra L. Weiner, Lois A. Kotkoskie.

Contributor(s): Material type: TextTextSeries: Drugs and the pharmaceutical sciences ; v.103Publisher: New York : M. Dekker, [2000]Copyright date: ©2000. Description: x, 370 pages : illustrations ; 24 cmContent type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
ISBN:
  • 0824782100 (alk. paper)
Subject(s): DDC classification:
  • 21 615.19 E
LOC classification:
  • RS201.E87 E96 2000
Online resources:
Contents:
pt. 1. Introduction to excipients -- What are excipients? -- Purity of excipients -- History of excipient safety and toxicity -- Regulation of pharmaceuicatl excipients -- pt. 2. Safety evaluation of pharamceutical excipients -- Development of safety evaluation guidelines -- Routes of exposure: oral -- Routes of exposure: topical and transdermal -- Routes of exposure: inhalation and intranasal -- Routes of exposure: parenteral -- Routes of exposure: other -- pt. 3. Risk assessment of excipients -- Toxicokinetics and hazard identification -- Exposure assessment -- Risk assessment and risk communication -- pt. 4. Future issues -- Harmonization of excipient standards.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)

Includes bibliographical references and index.

pt. 1. Introduction to excipients --
What are excipients? --
Purity of excipients --
History of excipient safety and toxicity --
Regulation of pharmaceuicatl excipients --
pt. 2. Safety evaluation of pharamceutical excipients --
Development of safety evaluation guidelines --
Routes of exposure: oral --
Routes of exposure: topical and transdermal --
Routes of exposure: inhalation and intranasal --
Routes of exposure: parenteral --
Routes of exposure: other --
pt. 3. Risk assessment of excipients --
Toxicokinetics and hazard identification --
Exposure assessment --
Risk assessment and risk communication --
pt. 4. Future issues --
Harmonization of excipient standards.

There are no comments on this title.

to post a comment.